Asthma Clinical Trial
Official title:
An Evaluation of Changes in Physician Performance Through Continuous Professional Development
Verified date | February 2009 |
Source | Henry Ford Health System |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The purpose of this study is to determine whether having physicians evaluate their management of certain diseases as part of board recertification results in improved patient care.
Status | Completed |
Enrollment | 40 |
Est. completion date | December 2006 |
Est. primary completion date | July 2006 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Previously board-certified in internal medicine - Practicing general internist within the Henry Ford Medical Group Exclusion Criteria: |
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Single Blind
Country | Name | City | State |
---|---|---|---|
United States | Henry Ford Health System | Detroit | Michigan |
Lead Sponsor | Collaborator |
---|---|
Henry Ford Health System |
United States,
Benson JA Jr. Certification and recertification: one approach to professional accountability. Ann Intern Med. 1991 Feb 1;114(3):238-42. — View Citation
Campbell C, Parboosingh J, Gondocz T, Babitskaya G, Pham B. A study of the factors that influence physicians' commitments to change their practices using learning diaries. Acad Med. 1999 Oct;74(10 Suppl):S34-6. — View Citation
Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995 Sep 6;274(9):700-5. — View Citation
Glassock RJ, Benson JA Jr, Copeland RB, Godwin HA Jr, Johanson WG Jr, Point W, Popp RL, Scherr L, Stein JH, Taunton OD. Time-limited certification and recertification: the program of the American Board of Internal Medicine. The Task Force on Recertification. Ann Intern Med. 1991 Jan 1;114(1):59-62. — View Citation
Kassirer JP. ABIM looks toward the future. Am J Med. 1996 Feb;100(2):123-4. — View Citation
Norcini JJ, Lipner R, Downing SM. How meaningful are scores on a take-home recertification examination? Acad Med. 1996 Oct;71(10 Suppl):S71-3. — View Citation
Norcini JJ, Lipner RS. Recertification: is there a link between take-home and proctored examinations? Acad Med. 1999 Oct;74(10 Suppl):S28-30. — View Citation
Wasserman SI, Kimball HR, Duffy FD. Recertification in internal medicine: a program of continuous professional development. Task Force on Recertification. Ann Intern Med. 2000 Aug 1;133(3):202-8. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 1) The proportion of patients prescribed inhaled corticosteroids | |||
Secondary | 1) The proportion of patients reporting instruction on the proper inhaler technique | |||
Secondary | 2) The proportion of patients reporting that asthma triggers were discussed | |||
Secondary | 3) The proportion of patients instructed to use short-acting beta-agonists as needed. | |||
Secondary | 4) The proportion of patients instructed to use a peak flow meter | |||
Secondary | 5) The proportion of patients who received a written action plan for exacerbations | |||
Secondary | 6) The proportion of patients reporting nocturnal asthma symptoms in the past month | |||
Secondary | 7) The proportion of patients reporting regular use of a rescue inhaler daily. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|